The Biostatistics team at GoBroad Clinical Research Center comprises seasoned statisticians with extensive industry experiences, particularly in specialized areas such as hematology, oncology, neuroscience, CGT, and early-phase innovative trials (including CQT, TQT, mass balance, drug-drug interactions, etc.).

The team members actively participate in the statistical design of clinical research, applying model based early phase statistical design (e.g. Bayesian theory), adaptive design, real-world data, and more to optimize clinical protocols. They support study simulation, data mining, meta-analysis, and the formulation of regulatory submission strategies (FDA, EMA, PMDA, CDE, etc.), facilitating interactions with regulatory agencies. Additionally, the team can provide Data Monitoring Committee (DMC) and centralized monitoring services. Furthermore, Biostatistics collaborates with the Quantitative Pharmacology department to offer technical support in early development. Besides, the team are also experienced to support clinicians to publish scientific papers on statistical sides, including many top journals, e.g. New England Journal of Medicine (NEJM), The Lancet, JAMA, BMJ, and Lancet Oncology, JCO, Blood, etc。